3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one

C167H170N22O15 — CID 157439522

IUPAC3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one
SMILESCCCCN(CCC#N)c1ccc(C2(c3c(C)n(CC)c4ccccc34)OC(=O)c3nccnc32)cc1.CCN(CC)c1ccc(C2(c3c(C)n(C)c4ccccc34)OC(=O)c3nccnc32)c(C)c1.CCN(CC)c1ccc(C2(c3c(C)n(C)c4ccccc34)OC(=O)c3nccnc32)c(OC(C)=O)c1.CCN(CC)c1ccc(C2(c3c(C)n(CC)c4ccccc34)OC(=O)c3cccnc32)c(C)c1.CCOc1cc(N(CC)CC)ccc1C1(c2c(C)n(C)c3ccccc23)OC(=O)c2cccnc21.CCn1c(C)c(C2(c3ccc(C)cc3)OC(=O)c3nccnc32)c2ccccc21
InChIInChI=1S/C30H31N5O2.C29H31N3O3.C29H31N3O2.C28H28N4O4.C27H28N4O2.C24H21N3O2/c1-4-6-19-34(20-9-16-31)23-14-12-22(13-15-23)30(28-27(29(36)37-30)32-17-18-33-28)26-21(3)35(5-2)25-11-8-7-10-24(25)26;1-6-32(7-2)20-15-16-23(25(18-20)34-8-3)29(27-22(28(33)35-29)13-11-17-30-27)26-19(4)31(5)24-14-10-9-12-21(24)26;1-6-31(7-2)21-15-16-24(19(4)18-21)29(27-23(28(33)34-29)13-11-17-30-27)26-20(5)32(8-3)25-14-10-9-12-22(25)26;1-6-32(7-2)19-12-13-21(23(16-19)35-18(4)33)28(26-25(27(34)36-28)29-14-15-30-26)24-17(3)31(5)22-11-9-8-10-20(22)24;1-6-31(7-2)19-12-13-21(17(3)16-19)27(25-24(26(32)33-27)28-14-15-29-25)23-18(4)30(5)22-11-9-8-10-20(22)23;1-4-27-16(3)20(18-7-5-6-8-19(18)27)24(17-11-9-15(2)10-12-17)22-21(23(28)29-24)25-13-14-26-22/h7-8,10-15,17-18H,4-6,9,19-20H2,1-3H3;9-18H,6-8H2,1-5H3;9-18H,6-8H2,1-5H3;8-16H,6-7H2,1-5H3;8-16H,6-7H2,1-5H3;5-14H,4H2,1-3H3
InChIKeyBRMQVLYCYFGOOF-UHFFFAOYSA-N
MW2725.34 g/mol
LogP31.25
Rot. Bonds36

About 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one

3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one (PubChem CID 157439522) has the molecular formula C167H170N22O15 and a molecular weight of 2725.34 g/mol. Its IUPAC name is 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one.

Molecular Properties

Compound Name3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one
PubChem CID157439522
Molecular FormulaC167H170N22O15
Molecular Weight2725.34 g/mol
Exact Mass2723.32
IUPAC Name3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one
SMILESCCCCN(CCC#N)c1ccc(C2(c3c(C)n(CC)c4ccccc34)OC(=O)c3nccnc32)cc1.CCN(CC)c1ccc(C2(c3c(C)n(C)c4ccccc34)OC(=O)c3nccnc32)c(C)c1.CCN(CC)c1ccc(C2(c3c(C)n(C)c4ccccc34)OC(=O)c3nccnc32)c(OC(C)=O)c1.CCN(CC)c1ccc(C2(c3c(C)n(CC)c4ccccc34)OC(=O)c3cccnc32)c(C)c1.CCOc1cc(N(CC)CC)ccc1C1(c2c(C)n(C)c3ccccc23)OC(=O)c2cccnc21.CCn1c(C)c(C2(c3ccc(C)cc3)OC(=O)c3nccnc32)c2ccccc21
InChIInChI=1S/C30H31N5O2.C29H31N3O3.C29H31N3O2.C28H28N4O4.C27H28N4O2.C24H21N3O2/c1-4-6-19-34(20-9-16-31)23-14-12-22(13-15-23)30(28-27(29(36)37-30)32-17-18-33-28)26-21(3)35(5-2)25-11-8-7-10-24(25)26;1-6-32(7-2)20-15-16-23(25(18-20)34-8-3)29(27-22(28(33)35-29)13-11-17-30-27)26-19(4)31(5)24-14-10-9-12-21(24)26;1-6-31(7-2)21-15-16-24(19(4)18-21)29(27-23(28(33)34-29)13-11-17-30-27)26-20(5)32(8-3)25-14-10-9-12-22(25)26;1-6-32(7-2)19-12-13-21(23(16-19)35-18(4)33)28(26-25(27(34)36-28)29-14-15-30-26)24-17(3)31(5)22-11-9-8-10-20(22)24;1-6-31(7-2)19-12-13-21(17(3)16-19)27(25-24(26(32)33-27)28-14-15-29-25)23-18(4)30(5)22-11-9-8-10-20(22)23;1-4-27-16(3)20(18-7-5-6-8-19(18)27)24(17-11-9-15(2)10-12-17)22-21(23(28)29-24)25-13-14-26-22/h7-8,10-15,17-18H,4-6,9,19-20H2,1-3H3;9-18H,6-8H2,1-5H3;9-18H,6-8H2,1-5H3;8-16H,6-7H2,1-5H3;8-16H,6-7H2,1-5H3;5-14H,4H2,1-3H3
InChIKeyBRMQVLYCYFGOOF-UHFFFAOYSA-N
XLogP31.25
TPSA391.80 Ų
H-Bond Donors
H-Bond Acceptors37
Rotatable Bonds36
Heavy Atoms204
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002725.34
LogP ≤ 531.25
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'phenol_ester', 'substructure': 'N/A'}

Analyze 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one?
The IUPAC name of 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one (CID 157439522) is 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one.
What is the SMILES notation for 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one?
The canonical SMILES for 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one is CCCCN(CCC#N)c1ccc(C2(c3c(C)n(CC)c4ccccc34)OC(=O)c3nccnc32)cc1.CCN(CC)c1ccc(C2(c3c(C)n(C)c4ccccc34)OC(=O)c3nccnc32)c(C)c1.CCN(CC)c1ccc(C2(c3c(C)n(C)c4ccccc34)OC(=O)c3nccnc32)c(OC(C)=O)c1.CCN(CC)c1ccc(C2(c3c(C)n(CC)c4ccccc34)OC(=O)c3cccnc32)c(C)c1.CCOc1cc(N(CC)CC)ccc1C1(c2c(C)n(C)c3ccccc23)OC(=O)c2cccnc21.CCn1c(C)c(C2(c3ccc(C)cc3)OC(=O)c3nccnc32)c2ccccc21.
What is the InChIKey of 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one?
The InChIKey is BRMQVLYCYFGOOF-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H31N5O2.C29H31N3O3.C29H31N3O2.C28H28N4O4.C27H28N4O2.C24H21N3O2/c1-4-6-19-34(20-9-16-31)23-14-12-22(13-15-23)30(28-27(29(36)37-30)32-17-18-33-28)26-21(3)35(5-2)25-11-8-7-10-24(25)26;1-6-32(7-2)20-15-16-23(25(18-20)34-8-3)29(27-22(28(33)35-29)13-11-17-30-27)26-19(4)31(5)24-14-10-9-12-21(24)26;1-6-31(7-2)21-15-16-24(19(4)18-21)29(27-23(28(33)34-29)13-11-17-30-27)26-20(5)32(8-3)25-14-10-9-12-22(25)26;1-6-32(7-2)19-12-13-21(23(16-19)35-18(4)33)28(26-25(27(34)36-28)29-14-15-30-26)24-17(3)31(5)22-11-9-8-10-20(22)24;1-6-31(7-2)19-12-13-21(17(3)16-19)27(25-24(26(32)33-27)28-14-15-29-25)23-18(4)30(5)22-11-9-8-10-20(22)23;1-4-27-16(3)20(18-7-5-6-8-19(18)27)24(17-11-9-15(2)10-12-17)22-21(23(28)29-24)25-13-14-26-22/h7-8,10-15,17-18H,4-6,9,19-20H2,1-3H3;9-18H,6-8H2,1-5H3;9-18H,6-8H2,1-5H3;8-16H,6-7H2,1-5H3;8-16H,6-7H2,1-5H3;5-14H,4H2,1-3H3.
What are the key properties of 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one?
3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one has a molecular weight of 2725.34 g/mol, XLogP of 31.25, 36 rotatable bonds, 0 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[N-butyl-4-[5-(1-ethyl-2-methylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]anilino]propanenitrile;[5-(diethylamino)-2-[5-(1,2-dimethylindol-3-yl)-7-oxofuro[3,4-b]pyrazin-5-yl]phenyl] acetate;7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1,2-dimethylindol-3-yl)furo[3,4-b]pyridin-5-one;5-[4-(diethylamino)-2-methylphenyl]-5-(1,2-dimethylindol-3-yl)furo[3,4-b]pyrazin-7-one;7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethyl-2-methylindol-3-yl)furo[3,4-b]pyridin-5-one;5-(1-ethyl-2-methylindol-3-yl)-5-(4-methylphenyl)furo[3,4-b]pyrazin-7-one is sourced from PubChem (CID 157439522), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).